Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA grants approval to WISE for neuromonitoring cortical strip

December 2, 2022
Medical Communications

WISE, a medical equipment manufacturer based in Italy, has obtained FDA approval for its single-use medical device WISE Cortical Strip …

News

Eli Lilly’s COVID-19 drug bebtelovimab loses FDA authorisation

December 1, 2022
Manufacturing and Production

The FDA have announced that Eli Lilly’s COVID-19 drug bebtelovimab is not authorised for emergency use in the US, as …

News

Pulmonx secure Japanese approval for Zephyr Valve for COPD/emphysema

December 1, 2022
Medical Communications

Pulmonx, a US-based medical technology company, has secured approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for …

News

FDA approves Ferring’s first-in-class microbiota-based live biotherapeutic

December 1, 2022
Medical Communications

Switzerland-based Ferring Pharmaceuticals announced the FDA has approved its biotherapeutic REBYOTA®, indicated for the prevention of recurrence of Clostridioides difficile …

News

Elon Musk’s Neuralink to conduct human trials in 2023

December 1, 2022
Research and Development

Neuralink owner Elon Musk announced that he has submitted paperwork to the FDA which he hopes will allow Neuralink to …

News

Stem cell transplants could be offered to MS patients in new trial

November 30, 2022
Research and Development

In a world-first trial, the University of Sheffield and Sheffield Teaching Hospital NHS Foundation Trust will investigate the efficacy of …

News

Collaboration between BioNTech and Ryvu Therapeutics to develop and commercialise immuno-modulatory small molecule candidates

November 30, 2022
Research and Development

Ryvu Therapeutics, a clinical-stage oncology therapeutics development company, has announced a collaboration with BioNTech, which will consist of two parts: …

News

New Alzheimer’s drug, lecanemab slows disease but divides opinions

November 30, 2022
Research and Development

Japanese drugmaker Eisai and its US partner Biogen have announced that their new drug to treat Alzheimer’s disease appeared to …

News

RadNet’s Aidence AI subsidiary and Google Health enter into agreement to bring lung cancer screening model to market

November 30, 2022
Research and Development

Aidence, an AI subsidiary of RadNet which looks at lung health, has partnered with Google Health to license Google Health’s …

News
incyte_headshot

Peter Williams

November 29, 2022
Business Services

Incyte has announced its appointment of Peter Williams as General Manager for the UK and Ireland division. His new role …

Appointment

University of Texas and Novartis Pharmaceuticals develop new computer platform for easier drug discovery

November 29, 2022
Research and Development

Researchers from both the University of Texas, US and Novartis Pharmaceuticals have developed a computer-based platform which appears to make …

News

AstraZeneca to acquire Neogene for up to $320m

November 29, 2022
Sales and Marketing

AstraZeneca has announced that it is planning to buy Neogene for up to $320m. Biotechnology group Neogene has a focus …

News

Full-Life Technologies to acquire Focus-X Therapeutics

November 29, 2022
Sales and Marketing

Full-Life Technologies, a fully integrated global radiotherapeutics company, has announced that they have agreed to acquire US-based Focus-X Therapeutics.  

News

Siemens Healthineers and Atrium Health team up in $140m deal

November 29, 2022
Sales and Marketing

Atrium Health, a US-based non-profit health provider, has signed a partnership with Siemens Healthineers to buy $140m worth of healthcare …

News

Scott Curley

November 28, 2022
Business Services

Following a positive NICE recommendation for VAZKEPA® (icosapent ethyl), which has allowed Amarin to continue with its commercial expansion, Amarin …

Appointment

Bayer and Orion Corporation-developed prostate cancer treatment approved by NHS England and MHRA

November 28, 2022
Medical Communications

NHS England and the Medicines and Healthcare products Regulatory Agency have approved a prostate cancer treatment, developed jointly by Bayar …

News

Brainomix and Pixyl partner to offer multiple sclerosis treatment

November 28, 2022
Medical Communications

In a new partnership, UK-based medical software developer Brainomix will distribute Neuro.MS ‒ French medical imaging company Pixyl’s Software as …

News

C4X Discovery signs licensing deal worth up to $402m with AstraZeneca

November 28, 2022
Sales and Marketing

Pioneering drug discovery company, C4X Discovery Holdings (C4XD) has signed a licensing agreement with AstraZeneca, worth up to $402m. The …

News

Two-dose chemotherapy drug enters clinical trial for cancer patients

November 28, 2022
Research and Development

South Korean biotech firm Hyundai Bioscience’s innovative chemotherapy drug may be able to complete cancer treatments in two doses. The …

News

NHS nurses strike announced for 15 and 20 December

November 25, 2022
Medical Communications

The Royal College of Nursing (RCN) has announced strikes on 15 and 20 December in a continuing pay dispute with …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025